Foot-and-Mouth Disease (FMD) caused by the Foot-and-Mouth Disease Virus (FMDV) is the most economically significant disease of domestic livestock.

In response to the 1997/99 outbreak of FMD in swine and cattle in Taiwan, UBI has developed a series of highly specific peptide-based diagnostic tests capable of detecting FMDV infection, and uniquely capable of differentiating FMD-vaccinated from infected animals. This gave UBI a competitive advantage in confronting the full-blown FMD pandemic that emerged in 2001.

The UBI FMDV differential diagnostics represent a tremendous advance to the management of FMD outbreaks, and will provide significant economic benefit to the agricultural industry of Taiwan and other areas of the world now enduring FMD outbreaks. The Office International des Epizooties (OIE), the international organization that works with the UN's FAO agency to control FMDV, recommends the use of differential diagnostics as a tool for monitoring FMDV and for establishment of FMDV-free status. UBI now produces, the UBI® FMDV ELISAs. These are the best user-friendly commercial scale tests in the world that detect FMDV infection and differentiate vaccinated from infected animals.

UBI® FMDV NS is used in investigatory tests for the confirmation of seroreactivity on FMDV NONSTRUCTURAL PROTEIN ELISA kits. UBI® FMDV NS Neutralization Buffer is used in conjunction with the UBI® FMDV NS ELISA (SWINE) or (CATTLE) kits for the confirmatory testing of samples that are repeatably reactive by FMDV NONSTRUCTURAL PROTEIN ELISA screening tests.